Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 212 | 122 | 142 | 56 | 77 |
| Cost of Goods | 70 | 54 | 80 | 18 | 51 |
| Gross Profit | 142 | 68 | 62 | 38 | 26 |
| Operating Expenses | 3,014 | 6,623 | 2,527 | 4,404 | 2,271 |
| Operating Income | -2,802 | -6,501 | -2,385 | -4,348 | -2,194 |
| Other Income | 17 | -2 | 4 | 4 | 406 |
| Pre-tax Income | -2,785 | -6,503 | -2,381 | -4,344 | -1,788 |
| Net Income Continuous | -2,785 | -6,503 | -2,381 | -4,344 | -1,788 |
| Net Income | $-2,785 | $-6,503 | $-2,381 | $-4,344 | $-1,788 |
| EPS Basic Total Ops | -0.05 | -0.12 | -0.05 | -0.09 | -0.04 |
| EPS Basic Continuous Ops | -0.05 | -0.13 | -0.05 | -0.09 | -0.04 |
| EPS Diluted Total Ops | -0.05 | -0.12 | -0.05 | -0.09 | -0.04 |
| EPS Diluted Continuous Ops | -0.05 | -0.13 | -0.05 | -0.09 | -0.04 |
| EBITDA(a) | $-2,640 | $-6,336 | $-2,219 | $-4,185 | $-2,037 |